Skip to main content
BIOX
NASDAQ Industrial Applications And Services

Court Finds Bioceres Liable for Debt Defaults, Increases Q3 Net Loss to $13.4M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Industrial
Sentiment info
Negative
Importance info
9
Price
$0.373
Mkt Cap
$23.578M
52W Low
$0.347
52W High
$5
52W Position info
7.3% above low
Off High info
93% below high
Rel. Volume info
2.3× avg
Market data snapshot near publication time

BIOX is trading near its 52-week low of $0.347 (7.3% above the low) on elevated volume (2.3× avg).

Summary

Bioceres Crop Solutions faces a major legal setback as a New York court found it liable for multiple debt defaults and validly accelerated obligations, while also amending its Q3 net loss to $13.4 million due to an additional provision.


Key Events · Legal and Risk Events · BIOX

  • Court Rules Against Company in Debt Dispute

    A New York court granted partial summary judgment on liability against Bioceres and its guarantors, finding multiple events of default and valid acceleration of obligations related to over $100 million in notes.

  • Increased Q3 Net Loss

    The company amended its fiscal third-quarter 2026 earnings, reporting a net loss of $13.4 million, an increase of $3.4 million from the previously reported $10.0 million, due to an additional provision for contingent payment obligations.

  • Significant Financial Risk

    The court's finding of liability for accelerated debt obligations poses a severe financial threat to the company, which has a market capitalization of approximately $23.5 million and total debt of $227.8 million.


Analysis · BIOX · Industrial Applications And Services

A New York court has ruled against Bioceres Crop Solutions, finding the company and its guarantors liable for multiple events of default and confirming the valid acceleration of over $100 million in notes. This is a critical legal defeat that significantly increases the company's financial risk and uncertainty, especially given its small market capitalization and existing debt load. While the exact damages and financial penalties are yet to be determined, the finding of liability itself is a severe blow. Additionally, the company amended its fiscal third-quarter earnings, increasing its net loss by $3.4 million to $13.4 million, reflecting a reassessment of contingent payment obligations.

At the time of this filing, BIOX was trading at $0.37 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $23.6M. The 52-week trading range was $0.35 to $5.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BIOX - Latest Insights

BIOX
Jul 07, 2026, 7:08 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $0.3294
Real-time Price: $0.3501 info
Change: +$0.0207 (+6%) info
Market Cap: $22.136M info
BIOX
Jun 01, 2026, 5:16 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $0.4837
Real-time Price: $0.3501 info
Change: -$0.1336 (-28%) info
Market Cap: $22.136M info
BIOX
Jun 01, 2026, 10:16 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.4338
Real-time Price: $0.3501 info
Change: -$0.0837 (-19%) info
Market Cap: $22.136M info
BIOX
May 12, 2026, 4:01 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.451
Real-time Price: $0.3501 info
Change: -$0.1009 (-22%) info
Market Cap: $22.136M info
BIOX
May 11, 2026, 5:00 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $0.557789
Real-time Price: $0.3501 info
Change: -$0.207689 (-37%) info
Market Cap: $22.136M info